Reveal the latest prices in 2024! Larotrectinib leads a new wave of anti-cancer!

Larotrectinib is an innovative anti-cancer drug that belongs to the category of targeted therapy. Its main function is to block the growth and division process of cancer cells by inhibiting the activity of the abnormal TRK protein in cancer patients with TRK (neuroprimitive ectodermal tumor) gene fusion.

Larotrectinib has been launched in China and has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in hospitals. For specific conditions, it is recommended to consult the local hospital pharmacy. In foreign markets, larotinib has two options: original drug and generic drug. Original drugs include the German version, the American version, the European version and the Hong Kong version, and the price is about 10,000 to 20,000 yuan. In comparison, generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is around two to three thousand. It is worth noting that the ingredients of original drugs and generic drugs are basically the same.

TRKgene fusion is a rare but present genetic abnormality found in a variety of tumors, which results in the production of abnormalTRK proteins, which in turn promotes the proliferation of cancer cells. Larotrectinib is unique in that it is highly targeted and specifically targets the abnormal form of TRK protein, making it a model of personalized treatment.

Clinical research and trial results show that larotrectinib can show significant efficacy in the treatment of patients with TRK gene fusion positivity. This includes tumor shrinkage or stabilization, resulting in improvements in patient survival and quality of life.

The personalized treatment concept of larotrectinib requires genetic testing before use to determine whether the patient hasTRK gene fusion. This customized treatment approach helps reduce unnecessary treatment exposure, improve treatment targeting, and minimize patient discomfort and side effects.